Motley Fool Article Stirs Quantum Stock Debate, but Our WAIT Rating Stands

What happened

IonQ shares have tumbled materially this year, and a new Motley Fool piece suggests the decline may create a buying opportunity compared with Rigetti Computing. Our latest deep value analysis, however, maintains a WAIT rating on IONQ at $32.40, arguing the stock already embeds successful execution of its manufacturing, NVIDIA partnership, and security expansion. The master report stresses that revenue growth is largely acquisition-driven—the SkyWater deal adds foundry capacity but weakens backlog visibility, as purchase orders are often cancellable. Technical milestones such as six tapeouts and Superion 256 prototypes are real, yet commercial proof remains thin, with only one pre-sold system and one named security contract. The article does not resolve the core tension: low earnings quality, rapid share count expansion to 429 million shares, and a valuation at 3.6 times book with no margin of safety.

Implication

Over the next 6-12 months, the key checkpoints are additional named Superion orders, disclosed absolute bookings growth, and repeat organic security wins. Until management proves that engineering speed translates into commercial demand without further dilution, the stock is vulnerable to continued compression. Our base, bear, and bull scenarios imply values of $31, $22, and $42, respectively, leaving no margin of safety at the current $32.40 price. We would only become constructive on evidence of organic revenue inflection or a meaningful pullback below $26.

Thesis delta

No change. The article's characterization of the decline as a buying opportunity repeats a common narrative but ignores the quality-of-growth and dilution concerns detailed in our analysis. We maintain our WAIT rating and require proof of organic commercial traction before reconsidering.